查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1873626

牛黃：全球市場佔有率和排名、總收入和需求預測（2025-2031 年）

Calculus Bovis - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 104 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2024 年全球胃石市場規模估計為 1.75 億美元，預計在預測期（2025-2031 年）內將以 15.8% 的複合年成長率成長，到 2031 年將調整至 5.04 億美元。

本報告對近期關稅調整和國際戰略反制措施對牛膽石（牛黃）跨境產業佈局、資本配置模式、區域經濟相互依存關係和供應鏈重組的影響進行了全面評估。

這些結石是傳統中醫中使用的牛膽結石。在中國和日本等國家，牛膽結石長期以來被用於治療各種疾病，包括高燒、抽搐和中風。在亞洲國家，牛膽結石有時會在屠宰時收集。這些結石是牛（一種屬於脊索動物門的哺乳動物）的乾燥牛。在膽囊中形成的結石稱為“膽結石”或“肝結石”，在膽管中形成的結石稱為“膽結石”，在肝管中形成的結石稱為“肝黃”。完整的結石主要呈橢圓形，質地輕盈，表面光滑，呈金黃色至黃褐色。在中醫中，牛膽結石被描述為具有清香、微苦微甘的味道，並具有清涼的功效。它們用於退燒、解毒和鎮靜神經。內服可治療高燒、昏迷、躁症、兒童痙攣症和抽搐，外用可治療咽喉痛、口腔炎、癰和中毒。

天然石材極為稀少，無法工業化生產，因此本報告將重點介紹兩種主要類型的產品：試管內培育石材和人造石材。

全球領先的胃石生產商包括建民集團、迪博藥業、明興藥業、仁齊藥業、紅茂藥業和同仁堂。前五大企業總合佔80%的市場佔有率，其中建民集團產量最大，佔20%。全球胃石生產主要集中在中國，中國消費量約佔全球市場的90%。依產品類型，胃石分為試管內培養胃石和人工胃石，前者市佔率高達75%。依應用領域分類，醫藥領域是最大的應用領域，市佔率達95%，其次是中藥領域。

腎結石市場的主要促進因素包括：

1. 資源稀缺：天然琥珀供應受到嚴重限制

生產瓶頸

病因：膽結石是病理產物。只有0.1-0.2%的牛膽結石能夠自發性形成，且其形成週期較長（3-5年）。

2. 政策法規：產業准入法規和標準升級

生產許可證管理

在中國，只有六家公司（包括建民集團和同仁堂）被允許生產天然琥珀，每年的配額不到 800 公斤。

2025 年版《中國藥典》將提高琥珀含量的檢測標準，將雜質的上限從 2% 收緊至 0.5%，迫使企業最佳化其採購和加工技術。

3. 高階消費：高階中醫的需求正在快速成長。

草藥學領域

安米亞牛黃丸：核心成分牛黃佔10%，年需求量超過200噸，推動牛黃使用量成長15%。

片彩帆：天然羚羊角製品單價超過1,000元/片，銷量較去年同期成長20%。

拓展至保健食品及化妝品領域

牛膽牙膏：含微量牛膽，單價是一般牙膏的五倍，市佔率每年成長 25%。

抗衰老產品：在高階護膚中使用方解石萃取物，目標客戶群預計將以 30% 的複合年成長率成長。

4. 技術替代方案：琥珀體外培養的技術突破

工業化進程加速

武漢建民大鵬藥業已實現試管培養牛黃的大規模生產，年產能達5噸，而成本僅為天然牛黃的十分之一。

功效檢驗：國家食品藥物管理局已核准該產品作為天然石頭的替代品用於42種中成藥中，覆蓋了80%的石頭製劑。

市場滲透率提高

雖然人工養殖的羚羊角佔據了中低價價格分佈市場 60% 以上的佔有率，從而降低了對天然羚羊角的需求，但在高階市場，人工養殖的羚羊角仍然難以被取代。

5. 資本主導：產業鏈整合與金融化

壟斷上游資源

片子黃和同仁堂透過擁有海外牧場保障了牛供應。

期貨和衍生

羚羊角期貨在亳州中藥交易所上市交易，年交易量超過50億元。價格發現機制有助於降低企業的採購風險。

6. 文化信仰：傳統醫學觀念根深蒂固

草藥的地位不可動搖。

在《神農本草經》中，留根被描述為上品，其作為中醫理論中「寒水三寶」之首的地位，加深了消費者的認可。

它已成為一件很有價值的禮物。

天然牛黃製品已成為高階禮品，單價超過10萬元的牛黃工藝品年銷售額超過10億元。

7. 挑戰與解決方案

永續供應問題

對策：推廣試管內培養技術，開發合成生物學途徑生產石英，減少對自然資源的依賴。

價格波動風險

對策：建立國家戰略儲備制度，加強期貨市場的避險方法，平滑企業的成本曲線。

琥珀市場是資源稀缺、政策限制、日益精細化的消費和技術替代等因素協同作用的典型例證。展望未來，該產業將呈現「高品質天然琥珀、大規模養殖技術、產業鏈金融化」的三重發展趨勢。企業必須透過技術創新、資源壟斷和文化行銷，在供應限制和需求激增之間尋求平衡，主導未來十年市場結構的變革。

本報告旨在按地區/國家、類型和應用對全球牛黃市場進行全面分析，重點關注總銷售量、收入、價格、市場佔有率和主要企業的排名。

本報告以銷售量（公斤）和收入（百萬美元）為單位，對牛黃市場規模、估算和預測進行了呈現，以2024年為基準年，並涵蓋了2020年至2031年的歷史數據和預測數據。定量和定性分析將幫助讀者制定牛黃業務和成長策略，評估市場競爭，分析自身在當前市場中的地位，並做出明智的商業決策。

市場區隔

公司

  • Jianmin Group
  • Dibo Pharmaceuticals
  • Ming Hing Pharmaceutical
  • Renqi Pharmaceutical
  • Hongmao Pharmaceutical
  • Tongrentang

按類型分類的細分市場

  • 人造石
  • 體外培養的結石

應用領域

  • 配藥
  • 草藥

按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 韓國
    • 東南亞
    • 印度
    • 澳洲
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 荷蘭
    • 北歐國家
    • 其他歐洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲
  • 中東和非洲
    • 土耳其
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他中東和非洲地區

The global market for Calculus Bovis was estimated to be worth US$ 175 million in 2024 and is forecast to a readjusted size of US$ 504 million by 2031 with a CAGR of 15.8% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Calculus Bovis cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Bezoar is a bovine gallstone used in traditional Chinese medicine. In countries such as China and Japan, it has long been used to treat a variety of diseases, including high fever, convulsions and stroke. In Asian countries, cattle stones are sometimes harvested when cattle are slaughtered. Bezoar is a dried gallstone of cattle, a mammal of the phylum Chordata. Those produced in the gallbladder are called "bile yellow" or "egg yolk", those produced in the bile duct are called "tube yellow", and those produced in the hepatic duct are called "liver yellow". The complete bezoar is mostly oval in shape, light in texture, with a golden to yellow-brown surface, delicate and shiny. Traditional Chinese medicine believes that bezoar has a fresh fragrance, a slightly bitter taste and then sweet, and a cool nature. It can be used to relieve fever, detoxify, and calm the nerves. It can be taken internally to treat high fever, coma, mania, infantile convulsions, convulsions, etc. It can be used externally to treat sore throat, mouth sores, carbuncle, and toxicity.

Because natural bezoar is extremely rare and cannot be produced industrially. Therefore, this report mainly counts two types of products: in vitro cultivated bezoar and artificial bezoar.

The global key manufacturers of calculus bovis include Jianmin Group, Dibo Pharmaceuticals, Mingxing Pharmaceuticals, Renqi Pharmaceuticals, Hongmao Pharmaceuticals, and Tongrentang. The top five manufacturers together account for 80% of the market share, with Jianmin Group being the largest producer with 20% of the market share. The global origin is mainly concentrated in China. At the consumer level, China holds close to 90% of the market share. In terms of product category, it is divided into in vitro calculus bovis and artificial bezoar, with the former having a higher market share of 75%. In terms of its application,preparations medicine is its top application area with 95% market share, followed by Chinese hebal medicine.

The driving factors of the bezoar market mainly include

1. Resource scarcity: rigid constraints on the supply of natural bezoar

Production bottleneck

Cause: Bezoar is a pathological product. Only 0.1%-0.2% of cattle gallstones can form natural bezoar, and the breeding cycle is long (requires 3-5 years).

2. Policy control: industry access and standard upgrade

Production license control

China only allows 6 companies (such as Jianmin Group and Tongrentang) to produce natural bezoar, and implements a quota system with an annual quota of less than 800 kilograms.

The 2025 edition of the "Chinese Pharmacopoeia" raises the detection standard for bezoar content, and the impurity limit is tightened from 2% to 0.5%, forcing companies to optimize procurement and processing technology.

3. Consumption upgrade: Demand for high-end Chinese medicine explodes

Chinese patent medicine field

Angong Niuhuang Wan: The core raw material bezoar accounts for 10%, and the annual demand exceeds 200 tons, driving the use of bezoar to increase by 15%.

Pianzaihuang: The unit price of natural bezoar formula products exceeds 1,000 yuan/tablet, and sales increase by 20% year-on-year.

Health products and cosmeceuticals extension

Bezoar toothpaste: adding trace amounts of bezoar ingredients, the unit price is 5 times that of ordinary toothpaste, and the market share increases by 25% annually.

Anti-aging products: bezoar extract is used for high-end skin care, and the target customer group CAGR reaches 30%.

4. Technology substitution: breakthrough in in vitro cultivation of bezoar

Industrialization process is accelerated

Wuhan Jianmin Dapeng Pharmaceutical has achieved large-scale production of in vitro cultivated bezoar, with a cost of only 1/10 of natural bezoar and an annual production capacity of 5 tons.

Efficacy verification: The State Food and Drug Administration has approved it to replace natural bezoar for 42 kinds of Chinese patent medicines, covering 80% of bezoar preparations.

Market penetration rate increases

In vitro cultivated bezoar has a market share of more than 60% in the low- and medium-end markets, squeezing out the demand for natural bezoar, but it is still irreplaceable in the high-end field.

5. Capital drive: industrial chain integration and financialization

Upstream resource monopoly

Pianzihuang and Tongrentang lock in cattle sources by holding overseas ranches.

Futures and financial derivatives

Bezoar futures are listed on the Bozhou Chinese Medicine Exchange, with an annual trading volume of over 5 billion yuan. The price discovery function reduces corporate procurement risks.

6. Cultural beliefs: Traditional medical cognition is solidified

The status of the pharmacopoeia is unshakable

The "Shennong Bencao Jing" lists bezoar as a top-grade product, and its status as the first of the "three treasures of cold water" in traditional Chinese medicine theory deepens consumer cognition.

Gift attributes are strengthened

Natural bezoar products have become high-end gifts, and the annual sales of bezoar handicrafts with a unit price of more than 100,000 yuan exceeds 1 billion yuan.

7. Challenges and coping strategies

Sustainable supply problems

Countermeasures: Promote in vitro cultivation technology, develop synthetic biology pathways for bezoar, and reduce dependence on natural resources.

Price volatility risk

Countermeasures: Establish a national strategic reserve system, improve hedging tools in the futures market, and smooth the cost curve of enterprises.

The bezoar market is a typical scenario of resource scarcity, policy control, consumption upgrades and technological substitution resonance. In the future, the industry will present the triple trends of "high-end natural bezoar, large-scale in vitro cultivation, and financialization of the industrial chain." Enterprises need to seek a balance between supply constraints and demand explosion through technological breakthroughs, resource monopoly and cultural marketing, and dominate the market structure in the next decade.

This report aims to provide a comprehensive presentation of the global market for Calculus Bovis, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Calculus Bovis by region & country, by Type, and by Application.

The Calculus Bovis market size, estimations, and forecasts are provided in terms of sales volume (kg) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Calculus Bovis.

Market Segmentation

By Company

  • Jianmin Group
  • Dibo Pharmaceuticals
  • Ming Hing Pharmaceutical
  • Renqi Pharmaceutical
  • Hongmao Pharmaceutical
  • Tongrentang

Segment by Type

  • Artificial Bezoar
  • In Vitro Cultured Bezoar

Segment by Application

  • Preparations Medicine
  • Chinese Herbal Medicine

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Calculus Bovis manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Calculus Bovis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Calculus Bovis in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Calculus Bovis Product Introduction
  • 1.2 Global Calculus Bovis Market Size Forecast
    • 1.2.1 Global Calculus Bovis Sales Value (2020-2031)
    • 1.2.2 Global Calculus Bovis Sales Volume (2020-2031)
    • 1.2.3 Global Calculus Bovis Sales Price (2020-2031)
  • 1.3 Calculus Bovis Market Trends & Drivers
    • 1.3.1 Calculus Bovis Industry Trends
    • 1.3.2 Calculus Bovis Market Drivers & Opportunity
    • 1.3.3 Calculus Bovis Market Challenges
    • 1.3.4 Calculus Bovis Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Calculus Bovis Players Revenue Ranking (2024)
  • 2.2 Global Calculus Bovis Revenue by Company (2020-2025)
  • 2.3 Global Calculus Bovis Players Sales Volume Ranking (2024)
  • 2.4 Global Calculus Bovis Sales Volume by Company Players (2020-2025)
  • 2.5 Global Calculus Bovis Average Price by Company (2020-2025)
  • 2.6 Key Manufacturers Calculus Bovis Manufacturing Base and Headquarters
  • 2.7 Key Manufacturers Calculus Bovis Product Offered
  • 2.8 Key Manufacturers Time to Begin Mass Production of Calculus Bovis
  • 2.9 Calculus Bovis Market Competitive Analysis
    • 2.9.1 Calculus Bovis Market Concentration Rate (2020-2025)
    • 2.9.2 Global 5 and 10 Largest Manufacturers by Calculus Bovis Revenue in 2024
    • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Calculus Bovis as of 2024)
  • 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Artificial Bezoar
    • 3.1.2 In Vitro Cultured Bezoar
  • 3.2 Global Calculus Bovis Sales Value by Type
    • 3.2.1 Global Calculus Bovis Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Calculus Bovis Sales Value, by Type (2020-2031)
    • 3.2.3 Global Calculus Bovis Sales Value, by Type (%) (2020-2031)
  • 3.3 Global Calculus Bovis Sales Volume by Type
    • 3.3.1 Global Calculus Bovis Sales Volume by Type (2020 VS 2024 VS 2031)
    • 3.3.2 Global Calculus Bovis Sales Volume, by Type (2020-2031)
    • 3.3.3 Global Calculus Bovis Sales Volume, by Type (%) (2020-2031)
  • 3.4 Global Calculus Bovis Average Price by Type (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Preparations Medicine
    • 4.1.2 Chinese Herbal Medicine
  • 4.2 Global Calculus Bovis Sales Value by Application
    • 4.2.1 Global Calculus Bovis Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Calculus Bovis Sales Value, by Application (2020-2031)
    • 4.2.3 Global Calculus Bovis Sales Value, by Application (%) (2020-2031)
  • 4.3 Global Calculus Bovis Sales Volume by Application
    • 4.3.1 Global Calculus Bovis Sales Volume by Application (2020 VS 2024 VS 2031)
    • 4.3.2 Global Calculus Bovis Sales Volume, by Application (2020-2031)
    • 4.3.3 Global Calculus Bovis Sales Volume, by Application (%) (2020-2031)
  • 4.4 Global Calculus Bovis Average Price by Application (2020-2031)

5 Segmentation by Region

  • 5.1 Global Calculus Bovis Sales Value by Region
    • 5.1.1 Global Calculus Bovis Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Calculus Bovis Sales Value by Region (2020-2025)
    • 5.1.3 Global Calculus Bovis Sales Value by Region (2026-2031)
    • 5.1.4 Global Calculus Bovis Sales Value by Region (%), (2020-2031)
  • 5.2 Global Calculus Bovis Sales Volume by Region
    • 5.2.1 Global Calculus Bovis Sales Volume by Region: 2020 VS 2024 VS 2031
    • 5.2.2 Global Calculus Bovis Sales Volume by Region (2020-2025)
    • 5.2.3 Global Calculus Bovis Sales Volume by Region (2026-2031)
    • 5.2.4 Global Calculus Bovis Sales Volume by Region (%), (2020-2031)
  • 5.3 Global Calculus Bovis Average Price by Region (2020-2031)
  • 5.4 North America
    • 5.4.1 North America Calculus Bovis Sales Value, 2020-2031
    • 5.4.2 North America Calculus Bovis Sales Value by Country (%), 2024 VS 2031
  • 5.5 Europe
    • 5.5.1 Europe Calculus Bovis Sales Value, 2020-2031
    • 5.5.2 Europe Calculus Bovis Sales Value by Country (%), 2024 VS 2031
  • 5.6 Asia Pacific
    • 5.6.1 Asia Pacific Calculus Bovis Sales Value, 2020-2031
    • 5.6.2 Asia Pacific Calculus Bovis Sales Value by Region (%), 2024 VS 2031
  • 5.7 South America
    • 5.7.1 South America Calculus Bovis Sales Value, 2020-2031
    • 5.7.2 South America Calculus Bovis Sales Value by Country (%), 2024 VS 2031
  • 5.8 Middle East & Africa
    • 5.8.1 Middle East & Africa Calculus Bovis Sales Value, 2020-2031
    • 5.8.2 Middle East & Africa Calculus Bovis Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Calculus Bovis Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Calculus Bovis Sales Value and Sales Volume
    • 6.2.1 Key Countries/Regions Calculus Bovis Sales Value, 2020-2031
    • 6.2.2 Key Countries/Regions Calculus Bovis Sales Volume, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Calculus Bovis Sales Value, 2020-2031
    • 6.3.2 United States Calculus Bovis Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Calculus Bovis Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Calculus Bovis Sales Value, 2020-2031
    • 6.4.2 Europe Calculus Bovis Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Calculus Bovis Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Calculus Bovis Sales Value, 2020-2031
    • 6.5.2 China Calculus Bovis Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Calculus Bovis Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Calculus Bovis Sales Value, 2020-2031
    • 6.6.2 Japan Calculus Bovis Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Calculus Bovis Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Calculus Bovis Sales Value, 2020-2031
    • 6.7.2 South Korea Calculus Bovis Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Calculus Bovis Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Calculus Bovis Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Calculus Bovis Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Calculus Bovis Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Calculus Bovis Sales Value, 2020-2031
    • 6.9.2 India Calculus Bovis Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Calculus Bovis Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 Jianmin Group
    • 7.1.1 Jianmin Group Company Information
    • 7.1.2 Jianmin Group Introduction and Business Overview
    • 7.1.3 Jianmin Group Calculus Bovis Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.1.4 Jianmin Group Calculus Bovis Product Offerings
    • 7.1.5 Jianmin Group Recent Development
  • 7.2 Dibo Pharmaceuticals
    • 7.2.1 Dibo Pharmaceuticals Company Information
    • 7.2.2 Dibo Pharmaceuticals Introduction and Business Overview
    • 7.2.3 Dibo Pharmaceuticals Calculus Bovis Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.2.4 Dibo Pharmaceuticals Calculus Bovis Product Offerings
    • 7.2.5 Dibo Pharmaceuticals Recent Development
  • 7.3 Ming Hing Pharmaceutical
    • 7.3.1 Ming Hing Pharmaceutical Company Information
    • 7.3.2 Ming Hing Pharmaceutical Introduction and Business Overview
    • 7.3.3 Ming Hing Pharmaceutical Calculus Bovis Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.3.4 Ming Hing Pharmaceutical Calculus Bovis Product Offerings
    • 7.3.5 Ming Hing Pharmaceutical Recent Development
  • 7.4 Renqi Pharmaceutical
    • 7.4.1 Renqi Pharmaceutical Company Information
    • 7.4.2 Renqi Pharmaceutical Introduction and Business Overview
    • 7.4.3 Renqi Pharmaceutical Calculus Bovis Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.4.4 Renqi Pharmaceutical Calculus Bovis Product Offerings
    • 7.4.5 Renqi Pharmaceutical Recent Development
  • 7.5 Hongmao Pharmaceutical
    • 7.5.1 Hongmao Pharmaceutical Company Information
    • 7.5.2 Hongmao Pharmaceutical Introduction and Business Overview
    • 7.5.3 Hongmao Pharmaceutical Calculus Bovis Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.5.4 Hongmao Pharmaceutical Calculus Bovis Product Offerings
    • 7.5.5 Hongmao Pharmaceutical Recent Development
  • 7.6 Tongrentang
    • 7.6.1 Tongrentang Company Information
    • 7.6.2 Tongrentang Introduction and Business Overview
    • 7.6.3 Tongrentang Calculus Bovis Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.6.4 Tongrentang Calculus Bovis Product Offerings
    • 7.6.5 Tongrentang Recent Development

8 Industry Chain Analysis

  • 8.1 Calculus Bovis Industrial Chain
  • 8.2 Calculus Bovis Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Calculus Bovis Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Calculus Bovis Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Calculus Bovis Market Trends
  • Table 2. Calculus Bovis Market Drivers & Opportunity
  • Table 3. Calculus Bovis Market Challenges
  • Table 4. Calculus Bovis Market Restraints
  • Table 5. Global Calculus Bovis Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Calculus Bovis Revenue Market Share by Company (2020-2025)
  • Table 7. Global Calculus Bovis Sales Volume by Company (2020-2025) & (kg)
  • Table 8. Global Calculus Bovis Sales Volume Market Share by Company (2020-2025)
  • Table 9. Global Market Calculus Bovis Price by Company (2020-2025) & (US$/kg)
  • Table 10. Key Manufacturers Calculus Bovis Manufacturing Base and Headquarters
  • Table 11. Key Manufacturers Calculus Bovis Product Type
  • Table 12. Key Manufacturers Time to Begin Mass Production of Calculus Bovis
  • Table 13. Global Calculus Bovis Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Calculus Bovis as of 2024)
  • Table 15. Mergers & Acquisitions, Expansion Plans
  • Table 16. Global Calculus Bovis Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 17. Global Calculus Bovis Sales Value by Type (2020-2025) & (US$ Million)
  • Table 18. Global Calculus Bovis Sales Value by Type (2026-2031) & (US$ Million)
  • Table 19. Global Calculus Bovis Sales Market Share in Value by Type (2020-2025)
  • Table 20. Global Calculus Bovis Sales Market Share in Value by Type (2026-2031)
  • Table 21. Global Calculus Bovis Sales Volume by Type: 2020 VS 2024 VS 2031 (kg)
  • Table 22. Global Calculus Bovis Sales Volume by Type (2020-2025) & (kg)
  • Table 23. Global Calculus Bovis Sales Volume by Type (2026-2031) & (kg)
  • Table 24. Global Calculus Bovis Sales Market Share in Volume by Type (2020-2025)
  • Table 25. Global Calculus Bovis Sales Market Share in Volume by Type (2026-2031)
  • Table 26. Global Calculus Bovis Price by Type (2020-2025) & (US$/kg)
  • Table 27. Global Calculus Bovis Price by Type (2026-2031) & (US$/kg)
  • Table 28. Global Calculus Bovis Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 29. Global Calculus Bovis Sales Value by Application (2020-2025) & (US$ Million)
  • Table 30. Global Calculus Bovis Sales Value by Application (2026-2031) & (US$ Million)
  • Table 31. Global Calculus Bovis Sales Market Share in Value by Application (2020-2025)
  • Table 32. Global Calculus Bovis Sales Market Share in Value by Application (2026-2031)
  • Table 33. Global Calculus Bovis Sales Volume by Application: 2020 VS 2024 VS 2031 (kg)
  • Table 34. Global Calculus Bovis Sales Volume by Application (2020-2025) & (kg)
  • Table 35. Global Calculus Bovis Sales Volume by Application (2026-2031) & (kg)
  • Table 36. Global Calculus Bovis Sales Market Share in Volume by Application (2020-2025)
  • Table 37. Global Calculus Bovis Sales Market Share in Volume by Application (2026-2031)
  • Table 38. Global Calculus Bovis Price by Application (2020-2025) & (US$/kg)
  • Table 39. Global Calculus Bovis Price by Application (2026-2031) & (US$/kg)
  • Table 40. Global Calculus Bovis Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 41. Global Calculus Bovis Sales Value by Region (2020-2025) & (US$ Million)
  • Table 42. Global Calculus Bovis Sales Value by Region (2026-2031) & (US$ Million)
  • Table 43. Global Calculus Bovis Sales Value by Region (2020-2025) & (%)
  • Table 44. Global Calculus Bovis Sales Value by Region (2026-2031) & (%)
  • Table 45. Global Calculus Bovis Sales Volume by Region (kg): 2020 VS 2024 VS 2031
  • Table 46. Global Calculus Bovis Sales Volume by Region (2020-2025) & (kg)
  • Table 47. Global Calculus Bovis Sales Volume by Region (2026-2031) & (kg)
  • Table 48. Global Calculus Bovis Sales Volume by Region (2020-2025) & (%)
  • Table 49. Global Calculus Bovis Sales Volume by Region (2026-2031) & (%)
  • Table 50. Global Calculus Bovis Average Price by Region (2020-2025) & (US$/kg)
  • Table 51. Global Calculus Bovis Average Price by Region (2026-2031) & (US$/kg)
  • Table 52. Key Countries/Regions Calculus Bovis Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 53. Key Countries/Regions Calculus Bovis Sales Value, (2020-2025) & (US$ Million)
  • Table 54. Key Countries/Regions Calculus Bovis Sales Value, (2026-2031) & (US$ Million)
  • Table 55. Key Countries/Regions Calculus Bovis Sales Volume, (2020-2025) & (kg)
  • Table 56. Key Countries/Regions Calculus Bovis Sales Volume, (2026-2031) & (kg)
  • Table 57. Jianmin Group Company Information
  • Table 58. Jianmin Group Introduction and Business Overview
  • Table 59. Jianmin Group Calculus Bovis Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 60. Jianmin Group Calculus Bovis Product Offerings
  • Table 61. Jianmin Group Recent Development
  • Table 62. Dibo Pharmaceuticals Company Information
  • Table 63. Dibo Pharmaceuticals Introduction and Business Overview
  • Table 64. Dibo Pharmaceuticals Calculus Bovis Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 65. Dibo Pharmaceuticals Calculus Bovis Product Offerings
  • Table 66. Dibo Pharmaceuticals Recent Development
  • Table 67. Ming Hing Pharmaceutical Company Information
  • Table 68. Ming Hing Pharmaceutical Introduction and Business Overview
  • Table 69. Ming Hing Pharmaceutical Calculus Bovis Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 70. Ming Hing Pharmaceutical Calculus Bovis Product Offerings
  • Table 71. Ming Hing Pharmaceutical Recent Development
  • Table 72. Renqi Pharmaceutical Company Information
  • Table 73. Renqi Pharmaceutical Introduction and Business Overview
  • Table 74. Renqi Pharmaceutical Calculus Bovis Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 75. Renqi Pharmaceutical Calculus Bovis Product Offerings
  • Table 76. Renqi Pharmaceutical Recent Development
  • Table 77. Hongmao Pharmaceutical Company Information
  • Table 78. Hongmao Pharmaceutical Introduction and Business Overview
  • Table 79. Hongmao Pharmaceutical Calculus Bovis Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 80. Hongmao Pharmaceutical Calculus Bovis Product Offerings
  • Table 81. Hongmao Pharmaceutical Recent Development
  • Table 82. Tongrentang Company Information
  • Table 83. Tongrentang Introduction and Business Overview
  • Table 84. Tongrentang Calculus Bovis Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 85. Tongrentang Calculus Bovis Product Offerings
  • Table 86. Tongrentang Recent Development
  • Table 87. Key Raw Materials Lists
  • Table 88. Raw Materials Key Suppliers Lists
  • Table 89. Calculus Bovis Downstream Customers
  • Table 90. Calculus Bovis Distributors List
  • Table 91. Research Programs/Design for This Report
  • Table 92. Key Data Information from Secondary Sources
  • Table 93. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Calculus Bovis Product Picture
  • Figure 2. Global Calculus Bovis Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Calculus Bovis Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Global Calculus Bovis Sales Volume (2020-2031) & (kg)
  • Figure 5. Global Calculus Bovis Sales Price (2020-2031) & (US$/kg)
  • Figure 6. Calculus Bovis Report Years Considered
  • Figure 7. Global Calculus Bovis Players Revenue Ranking (2024) & (US$ Million)
  • Figure 8. Global Calculus Bovis Players Sales Volume Ranking (2024) & (kg)
  • Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Calculus Bovis Revenue in 2024
  • Figure 10. Calculus Bovis Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 11. Artificial Bezoar Picture
  • Figure 12. In Vitro Cultured Bezoar Picture
  • Figure 13. Global Calculus Bovis Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 14. Global Calculus Bovis Sales Value Market Share by Type, 2024 & 2031
  • Figure 15. Global Calculus Bovis Sales Volume by Type (2020 VS 2024 VS 2031) & (kg)
  • Figure 16. Global Calculus Bovis Sales Volume Market Share by Type, 2024 & 2031
  • Figure 17. Global Calculus Bovis Price by Type (2020-2031) & (US$/kg)
  • Figure 18. Product Picture of Preparations Medicine
  • Figure 19. Product Picture of Chinese Herbal Medicine
  • Figure 20. Global Calculus Bovis Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 21. Global Calculus Bovis Sales Value Market Share by Application, 2024 & 2031
  • Figure 22. Global Calculus Bovis Sales Volume by Application (2020 VS 2024 VS 2031) & (kg)
  • Figure 23. Global Calculus Bovis Sales Volume Market Share by Application, 2024 & 2031
  • Figure 24. Global Calculus Bovis Price by Application (2020-2031) & (US$/kg)
  • Figure 25. North America Calculus Bovis Sales Value (2020-2031) & (US$ Million)
  • Figure 26. North America Calculus Bovis Sales Value by Country (%), 2024 VS 2031
  • Figure 27. Europe Calculus Bovis Sales Value, (2020-2031) & (US$ Million)
  • Figure 28. Europe Calculus Bovis Sales Value by Country (%), 2024 VS 2031
  • Figure 29. Asia Pacific Calculus Bovis Sales Value, (2020-2031) & (US$ Million)
  • Figure 30. Asia Pacific Calculus Bovis Sales Value by Region (%), 2024 VS 2031
  • Figure 31. South America Calculus Bovis Sales Value, (2020-2031) & (US$ Million)
  • Figure 32. South America Calculus Bovis Sales Value by Country (%), 2024 VS 2031
  • Figure 33. Middle East & Africa Calculus Bovis Sales Value, (2020-2031) & (US$ Million)
  • Figure 34. Middle East & Africa Calculus Bovis Sales Value by Country (%), 2024 VS 2031
  • Figure 35. Key Countries/Regions Calculus Bovis Sales Value (%), (2020-2031)
  • Figure 36. Key Countries/Regions Calculus Bovis Sales Volume (%), (2020-2031)
  • Figure 37. United States Calculus Bovis Sales Value, (2020-2031) & (US$ Million)
  • Figure 38. United States Calculus Bovis Sales Value by Type (%), 2024 VS 2031
  • Figure 39. United States Calculus Bovis Sales Value by Application (%), 2024 VS 2031
  • Figure 40. Europe Calculus Bovis Sales Value, (2020-2031) & (US$ Million)
  • Figure 41. Europe Calculus Bovis Sales Value by Type (%), 2024 VS 2031
  • Figure 42. Europe Calculus Bovis Sales Value by Application (%), 2024 VS 2031
  • Figure 43. China Calculus Bovis Sales Value, (2020-2031) & (US$ Million)
  • Figure 44. China Calculus Bovis Sales Value by Type (%), 2024 VS 2031
  • Figure 45. China Calculus Bovis Sales Value by Application (%), 2024 VS 2031
  • Figure 46. Japan Calculus Bovis Sales Value, (2020-2031) & (US$ Million)
  • Figure 47. Japan Calculus Bovis Sales Value by Type (%), 2024 VS 2031
  • Figure 48. Japan Calculus Bovis Sales Value by Application (%), 2024 VS 2031
  • Figure 49. South Korea Calculus Bovis Sales Value, (2020-2031) & (US$ Million)
  • Figure 50. South Korea Calculus Bovis Sales Value by Type (%), 2024 VS 2031
  • Figure 51. South Korea Calculus Bovis Sales Value by Application (%), 2024 VS 2031
  • Figure 52. Southeast Asia Calculus Bovis Sales Value, (2020-2031) & (US$ Million)
  • Figure 53. Southeast Asia Calculus Bovis Sales Value by Type (%), 2024 VS 2031
  • Figure 54. Southeast Asia Calculus Bovis Sales Value by Application (%), 2024 VS 2031
  • Figure 55. India Calculus Bovis Sales Value, (2020-2031) & (US$ Million)
  • Figure 56. India Calculus Bovis Sales Value by Type (%), 2024 VS 2031
  • Figure 57. India Calculus Bovis Sales Value by Application (%), 2024 VS 2031
  • Figure 58. Calculus Bovis Industrial Chain
  • Figure 59. Calculus Bovis Manufacturing Cost Structure
  • Figure 60. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 61. Bottom-up and Top-down Approaches for This Report
  • Figure 62. Data Triangulation
  • Figure 63. Key Executives Interviewed